Verano Holdings (VRNO) Profit After Tax (2021 - 2026)

Verano Holdings' (VRNO) quarterly Profit After Tax came in at -$17.8 million in Q1 2026, down 54.78% year-on-year from -$39.4 million in Q1 2025, and up 90.28% on a QoQ basis from -$183.4 million in Q4 2025.

Verano Holdings (VRNO) Profit After Tax (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Profit After Tax data on file, last reported at -$17.8 million in Q1 2026.

  • On a quarterly basis, Profit After Tax fell 54.78% year-over-year to -$17.8 million in Q1 2026; TTM through Mar 2026 was -$264.2 million, a 24.2% increase from a year earlier, with the FY2025 full-year figure at -$257.9 million, up 24.56% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$17.8 million, up from -$183.4 million in the prior quarter.
  • Over the last five years, Profit After Tax for VRNO reached as high as -$214000.0 in Q1 2022 and fell as low as -$272.7 million in Q4 2024.
  • Historically, Profit After Tax has averaged -$59.1 million across 5 years, with a median of -$19.2 million in 2025.
  • Across the five-year window, Profit After Tax surged 66.72% in 2022 and sank 4216.36% in 2023, its largest moves.
  • Year by year, Profit After Tax stood at -$216.1 million in 2022, then surged by 64.27% to -$77.2 million in 2023, then slumped by 253.21% to -$272.7 million in 2024, then jumped by 32.74% to -$183.4 million in 2025, then soared by 90.28% to -$17.8 million in 2026.
  • Per Business Quant data, the three most recent Profit After Tax figures were -$17.8 million in Q1 2026, -$183.4 million in Q4 2025, and -$43.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 369.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.35 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn -17.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -17.82 Mn
Dec 31, 2025 -183.41 Mn
Sep 30, 2025 -43.83 Mn
Jun 30, 2025 -19.15 Mn
Mar 31, 2025 -11.52 Mn
Dec 31, 2024 -272.71 Mn
Sep 30, 2024 -42.57 Mn
Jun 30, 2024 -21.76 Mn
Mar 31, 2024 -4.82 Mn
Dec 31, 2023 -77.21 Mn
Sep 30, 2023 -17.84 Mn
Jun 30, 2023 -13.06 Mn
Mar 31, 2023 -9.24 Mn
Dec 31, 2022 -216.11 Mn
Sep 30, 2022 -42.99 Mn
Jun 30, 2022 -9.85 Mn
Mar 31, 2022 -214,000.00
Dec 31, 2021 -6.83 Mn
Sep 30, 2021 -12.51 Mn
Jun 30, 2021 -29.59 Mn